RECRUITING

Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties

Talk to us

Conditions

Post Operative PainAnesthesiaNerve BlockShoulder OsteoarthritisShoulder ReplacementInterscalene blockPeripheral Nerve CatheterExparel

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter

Official Title

A Feasibility Randomized Control Comparison of Peripheral Interscalene Catheter to Liposomal Bupivacaine Single Injection for Interscalene Blocks Used in Pain Control for Total Shoulder Arthroplasties

Quick Facts

Study Start:2024-08-19
Study Completion:2025-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05868330

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Orthopedics service patients having reverse shoulder replacement surgery
  2. 2. ASA class I, II, or III.
  3. 3. Patients at least 18 years old but less than 90 years old.
  4. 4. Patients giving informed consent.
  5. 5. Non-Emergency Surgery
  1. 1. An inability to cooperate during the block placement.
  2. 2. Patients who do not meet criteria for a regional block: such as those on anti-coagulation,
  3. 3. Significant pulmonary disease or allergy to medications used for peripheral nerve blocks (Exparel, Bupivacaine and Ropivacaine)
  4. 4. Neuropathy of the planned extremity to block
  5. 5. Documented Kidney Failure
  6. 6. Documented Liver Failure
  7. 7. A lack of or inability to give informed consent.
  8. 8. Currently incarcerated.
  9. 9. Pregnant
  10. 10. Unable to communicate in English
  11. 11. Chronic pre-operative opioid use (greater than 20 MME opioid used)
  12. 12. Fracture
  13. 13. Revision surgery

Contacts and Locations

Study Contact

Melinda Seering, MD
CONTACT
5156895508
melinda-seering@uiowa.edu

Principal Investigator

Melinda Seering, MD
PRINCIPAL_INVESTIGATOR
University of Iowa

Study Locations (Sites)

University of Iowa Hospital and Clinics
Iowa City, Iowa, 52242
United States

Collaborators and Investigators

Sponsor: Melinda Seering

  • Melinda Seering, MD, PRINCIPAL_INVESTIGATOR, University of Iowa

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-19
Study Completion Date2025-01

Study Record Updates

Study Start Date2024-08-19
Study Completion Date2025-01

Terms related to this study

Keywords Provided by Researchers

  • Nerve Block
  • Shoulder Replacement
  • Interscalene block
  • Peripheral Nerve Catheter
  • Exparel

Additional Relevant MeSH Terms

  • Post Operative Pain
  • Anesthesia
  • Nerve Block
  • Shoulder Osteoarthritis